MichaelA.MatthayMD

Pulmonology • San Francisco, CA

Pleural Disease

Professor, Medicine, UCSF School of Medicine

Join to view full profile

Are you Dr. Matthay?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
505 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-353-2873

Fax+1 415-353-1990

Summary

Dr. Michael Matthay, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California, Florida, and Colorado. He is affiliated with UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center.

Education & Training

University of ColoradoResidency, Internal Medicine, 1973 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1973

Certifications & Licensure

CA State Medical License 1977 - 2025
FL State Medical License 2012 - 2016
CO State Medical License 1975 - 1983
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Start of enrollment: 1994 Sep 01
Completed
Phase 3
Activated Protein C to Treat Acute Lung Injuries Start of enrollment: 2005 Jan 01
Terminated
Phase 2
Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network
Completed
Phase 3
Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome Start of enrollment: 1997 Mar 01
Completed
Phase 3
The Effect of Nebulized Albuterol on Donor Oxygenation Start of enrollment: 2007 Apr 01
Completed
Phase 2
Drug Study of Albuterol to Treat Acute Lung Injury Start of enrollment: 2007 Aug 01
Terminated
Phase 2, Phase 3
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome Start of enrollment: 2013 Jul 01
Completed
Phase 1
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults Start of enrollment: 2013 Sep 01
Completed
Phase 4
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) Start of enrollment: 2014 Mar 15
Completed
Phase 2
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome Start of enrollment: 2019 Nov 26
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

8299 citations
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
Roy G. Brower, Michael A. Matthay, Alan H. Morris, David A. Schoenfeld, B. Taylor Thompson
The New England Journal of Medicine. 2000-05-04
180 citations
Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.
L. J. Mark Cross, Michael A. Matthay
Critical Care Clinics. 2011-04-01
50 citations
Alveolar Fluid Clearance in Pathologically Relevant Conditions: In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome.
Laura A. Huppert, Michael A. Matthay
Frontiers in Immunology. 2017-04-07

Press Mentions

Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone in Septic ShockMarch 27th, 2023
What Is ‘Flurona’, and Should You Worry About It During Flu Season? What Experts SayOctober 13th, 2021
Yes, You Can Have Covid-19 and the Flu at the Same Time. What That Could Do to You and Others Needing CareSeptember 29th, 2021
Join now to see all

Grant Support

Resolution Of Clinical Lung InjuryNational Heart, Lung, And Blood Institute2006–2012
Treatment Of Acute Lung Injury And Acute Respiratory Distress SyndromeNational Heart, Lung, And Blood Institute2011
Allogeneic Human Mesenchymal Stem Cells For The Treatment Of Acute Lung InjuryNational Heart, Lung, And Blood Institute2011
In Vitro And In Vivo Lung StudiesNational Institute Of Allergy And Infectious Diseases2008–2011
Lung Fluid Balance And Mesenchymal Stem CellsNational Heart, Lung, And Blood Institute2008–2011
Comparative Proteomic Investigation Of ARDS And Systemic Inflammatory InjuryNational Center For Research Resources2006–2010
ARDS - Eden ProtocolDivision Of Lung Diseases2009
Mechanisms Of Transfusion-Induced Lung Injury InNational Heart, Lung, And Blood Institute2005–2009
ARDSNational Heart, Lung, And Blood Institute2007
Therapy For Clinical Acute Lung Injury With APCNational Heart, Lung, And Blood Institute2003–2007
Sccor In Translational Research In Acute Lung InjuryNational Heart, Lung, And Blood Institute2003–2007
Mechanisms Of Alveolar Epithelial Fluid ClearanceNational Heart, Lung, And Blood Institute1994–2007
Compar Proteomics Of Edema Fluids In PATS W/ ARDS &Cardiogenic Pulmonary EdemaNational Center For Research Resources2004–2005
Resolution Of Clinical Lung InjuryNational Heart, Lung, And Blood Institute2001–2005
Core A- Administrative CoreNational Heart, Lung, And Blood Institute2003
Core--Cell Isolation And Culture CoreNational Institute Of Allergy And Infectious Diseases2002
Alveolar Epithelial Barrier In Clinical Lung InjuryNational Heart, Lung, And Blood Institute1996–2000
CCTG Clinical Network For ARDS Treatment--Critical CareDivision Of Lung Diseases1994–2000
Alveolar Epithelial Liquid And Protein ClearanceNational Heart, Lung, And Blood Institute1988
Mechanisms Of Alveolar ClearanceNational Heart, Lung, And Blood Institute1985